CHM-1 inhibits hepatocyte growth factor-induced invasion of SK-Hep-1 human hepatocellular carcinoma cells by suppressing matrix metalloproteinase-9 expression

Cancer Lett. 2007 Nov 8;257(1):87-96. doi: 10.1016/j.canlet.2007.07.002. Epub 2007 Aug 8.

Abstract

Clinical observations suggest that hepatocyte growth factor (HGF) can promote invasion and metastasis in hepatocellular carcinoma. In this study, we found that HGF-stimulated invasion of SK-Hep-1 cells, together with increased expression of matrix metalloproteinase (MMP)-9. CHM-1 was identified from 2-phenyl-4-quinolone derivatives to potently inhibit HGF-induced cell invasion, proteolytic activity, and expression of MMP-9. CHM-1 significantly inhibited tyrosine autophosphorylation of c-Met induced by HGF. CHM-1 also suppressed HGF-induced Akt phosphorylation, and NF-kappaB activation, the downstream regulators of HGF/c-Met signaling, resulting in the inhibition of MMP-9. Thus, we suggest that CHM-1 is a potential therapeutic agent against tumor invasion.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Cell Line, Tumor
  • Dioxoles / chemical synthesis*
  • Dioxoles / pharmacology*
  • Gene Expression Regulation, Neoplastic*
  • Hepatocyte Growth Factor / metabolism
  • Humans
  • I-kappa B Kinase / metabolism
  • Matrix Metalloproteinase 2 / metabolism
  • Matrix Metalloproteinase 9 / metabolism
  • Models, Biological
  • Models, Chemical
  • NF-kappa B / metabolism
  • Neoplasm Invasiveness
  • Neoplasm Metastasis
  • Phosphorylation
  • Quinolones / chemical synthesis*
  • Quinolones / pharmacology*

Substances

  • 2'-fluoro-6,7-methylenedioxy-2-phenyl-4-quinolone
  • Antineoplastic Agents
  • Dioxoles
  • NF-kappa B
  • Quinolones
  • Hepatocyte Growth Factor
  • I-kappa B Kinase
  • Matrix Metalloproteinase 2
  • Matrix Metalloproteinase 9